Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One? Didier ConcordetPeggy GandiaPierre-Louis Toutain Current Opinion Open access 21 August 2019 Pages: 1 - 5
Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma Nikki BlosserJennifer JuppDouglas Stewart Review Article 06 August 2019 Pages: 7 - 23
Update on Therapeutic Protein–Drug Interaction: Information in Labeling Xing JingPing JiChandrahas Sahajwalla Review Article 03 October 2019 Pages: 25 - 36
Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review Antoine PetitcollinAmina BensalemDavid Ternant Review Article 26 August 2019 Pages: 37 - 49
Physiologically Based Pharmacokinetic Modelling to Describe the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone According to Cytochrome P450 2D6 Phenotypes Lisa Alina KnellerFrancisco Abad-SantosGeorg Hempel Original Research Article 30 July 2019 Pages: 51 - 65
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease Rashmi MehtaColm FarrellDavid A. Lipson Original Research Article Open access 19 July 2019 Pages: 67 - 79
An Integrated Paediatric Population PK/PD Analysis of dDAVP: How do PK Differences Translate to Clinical Outcomes? Robin MicheletLien DosscheAn Vermeulen Original Research Article 25 July 2019 Pages: 81 - 96
Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women Paola MianJohn N. van den AnkerAndré Dallmann Original Research Article Open access 25 July 2019 Pages: 97 - 110
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies Ethan HoffmannGeorge G. NomikosHelen Colquhoun Original Research Article Open access 24 July 2019 Pages: 111 - 120
Correction to: Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy Elin M. SvenssonGunnar YngmanMats O. Karlsson Correction 02 November 2019 Pages: 121 - 121